| TECOVIRIMAT | SIGA TECHNOLOGIES | ||
| 200MG ; Capsule |
Less Than $1000 mn
|
||
| None | None | ||
| None | None | ||
| None | None | ||
| TPOXX is an inhibitor of the orthopoxvirus VP37 envelope wrapping protein and is indicated for the treatment of human smallpox disease in adults and pediatric patients weighing at least 3 kg. | |||
|
Yes
| |||
| TPOXX | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 |
|---|---|---|---|---|---|---|---|---|
| *** ********* | ||||||||
| *********, ************ *** ******* *** ********* *** ********** ** ************* ********** *** ********** ******** | *********, ************ *** ******* *** ********* *** ********** ** ************* ********** *** ********** ******** | *********, ************ *** ******* *** ********* *** ********** ** ************* ********** *** ********** ******** | *********, ************, *** ******* *** ********* *** ********** ** ************* ********** *** ********** ******** | *********** ***** ** **-*** *** ******* ** *********** | *********** ***** ** **-*** *** ******* ** *********** | *********, ************, *** ******* *** ********* *** ********** ** ************* ********** *** ********** ******** | *********** ***** ** **-*** *** ******* ** *********** |
| TECOVIRIMAT | SIGA TECHNOLOGIES | ||
| 200MG/20ML ; Solution |
Less Than $1000 mn
|
||
| None | None | ||
| None | None | ||
| None | None | ||
| TPOXX is an inhibitor of the orthopoxvirus VP37 envelope wrapping protein and is indicated for the treatment of human smallpox disease in adults and pediatric patients weighing at least 3 kg. | |||
|
Yes
| |||
| TPOXX | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 |
|---|---|---|---|---|---|---|---|---|
| *** ********* | ||||||||
| *********, ************ *** ******* *** ********* *** ********** ** ************* ********** *** ********** ******** | *********, ************ *** ******* *** ********* *** ********** ** ************* ********** *** ********** ******** | *********, ************ *** ******* *** ********* *** ********** ** ************* ********** *** ********** ******** | *********, ************, *** ******* *** ********* *** ********** ** ************* ********** *** ********** ******** | **-*** ****** ************ *** ******* | **-*** ****** ************ | **-*** ****** ************ *** ******* | *********, ************, *** ******* *** ********* *** ********** ** ************* ********** *** ********** ******** |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|